Skip to content

Trial to confirm the usefulness of pyrroloquinoline quinone disodium salt (PQQ) ingestion

Trial to confirm the usefulness of pyrroloquinoline quinone disodium salt (PQQ) ingestion - PQQ clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000048641
Enrollment
64
Registered
2023-12-20
Start date
2022-09-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N/A (healthy adults)

Interventions

Sponsors

Kyowa Trial Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Japanese males and females between the ages of 20 and less than 75 at the time of obtaining consent to participate in the test 2)Healthy persons who are not currently being treated for any serious illness 3)Those who score 13 or more points on the ADL (Activities of Daily Living Test) questionnaire administered beforehand 4)Those who can visit the designated facility on the scheduled visit date 5)Those who fully understand the purpose and content of this test and have agreed in writing

Exclusion criteria

Exclusion criteria: 1)Those who meet the diagnostic criteria for sarcopenia 2)Those who have a continuous exercise habit of at least 2 days per week 3)Those who have been attending the hospital for knee, back or other joint pain within 3 months 4)Those with a history of major surgery in the gastrointestinal tract area, such as gastrectomy, gastrointestinal suture, or intestinal resection 5)Those who have difficulty to participate in this study because of conditions i.e., liver, kidney, or cardiac disease, breathing, endocrinology, metabolism, nervous, or conscious disorder, diabetes (determined by JDA), and other diseases 6)Those with history of cardiovascular diseases 7)Those who regularly use amino acids or protein-enriched foods or beverages for the purpose of maintaining physical fitness, improving exercise function, or dieting 8)Those who have allergies related to test food 9)Those with a history or current history of hepatitis or those with circulatory system disease or severe anemia 10)Those who use medicines, health foods and supplements (including "Food for specified health uses", "Foods with function claims" and "Food with nutrient function claims") constantly, excepting those who can stop them at taking of informed consent 11)Previous experience of poor or worsened health after giving a blood sample 12)Blood donations 200 mL or more in the month before the trial or have plans for making a blood donation 200 mL or more during the trial period 13)Participation in another clinical trial, whether ongoing or within the last four weeks 14)Heavy drinkers and smokers 15)Extremely irregular dietary patterns 16)Late night and irregular shift workers 17)Those who do not wish to provide their consent to the details of the trial explained to them in advance 18)Those who judged that examination responsible doctor is not appropriate for this study participation

Design outcomes

Primary

MeasureTime frame
Lower limb extensor strength

Secondary

MeasureTime frame
1)10m shuttle walking 2)6-minute walking test 3)Grip strength 4)10m walking test

Countries

Japan

Contacts

Public ContactMegumi Takahashi

Ryusendo Co., Ltd. Development Division

m.takahashi@ryusendo.co.jp03-3985-8346

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026